Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies
Open Access
- 23 September 2021
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 40 (4) , 915-927
Abstract
Aim: Optimal management of bladder cancer requires an accurate, standardised and timely pathological diagnosis, and close communication between surgeons and pathologists. Here, we provide an update on pathology reporting standards of transurethral resections of the bladder and cystectomies. Methods: We reviewed recent literature, focusing on developments between 2013 and 2021. Results: Published reporting standards developed by pathology organizations have improved diagnosis and treatment. Tumor sub-staging and subtyping has gained increased attention. Lymph nodes continue to be an area of debate, and their staging has seen minor modifications. Several tasks, particularly regarding specimen preparation (“grossing”), are not yet standardized and offer opportunity for improvement. Molecular classification is rapidly evolving, but currently has only limited impact on management. Conclusion: Pathological reporting of bladder cancer is continuously evolving and remains challenging in some areas. This review provides an overview of recent major developments, with a particular focus on published reporting standards.Keywords
Funding Information
- Medical University of Vienna
This publication has 77 references indexed in Scilit:
- Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non‐metastatic carcinoma invading bladder muscle: results from a nationwide case–control studyBJU International, 2013
- Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 casesPathology, 2010
- Comparison of the new American Joint Committee on Cancer substratification in node‐negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary seriesBJU International, 2010
- To Count and How to Count, That Is the QuestionAmerican Journal of Clinical Pathology, 2010
- Clinical Epidemiology of Nonurothelial Bladder Cancer: Analysis of The Netherlands Cancer RegistryJournal of Urology, 2010
- Critical Evaluation of the Prostate from Cystoprostatectomies for Bladder Cancer: Insights from a Complete Sampling with the Whole Mount TechniqueEuropean Urology, 2009
- Urothelial Carcinoma with Divergent Histologic Differentiation (Mixed Histologic Features) Predicts the Presence of Locally Advanced Bladder Cancer When Detected at Transurethral ResectionUrology, 2007
- Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancerCancer, 2006
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous CarcinomaAmerican Journal of Surgical Pathology, 1994